REFERENCES
- Seaton A. Nanotechnology and the occupational physician. Occup Med (Lond). Aug, 2006; 56(5)312–316
- Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. Jul, 2005; 113(7)823–839
- Enüstün BV, Turkevich J. Coagulation of colloidal gold. J Am Chem Soc. 1963; 85: 3317–3328
- Hone DC, Haines AH, David A. Russell, rapid, quantitative colorimetric detection of a lectin using mannose-stabilized gold nanoparticles. Langmuir. 2003; 19: 7141–7144
- Haruta M. When gold is not noble: Catalysis by nanoparticles. Chem Rec. 2003; 3(2)75–87
- Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H, the ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group. Principles for characterizing the potential human health effects from exposure to nanomaterials: Elements of a screening strategy. Part Fibre Toxicol. Oct 6, 2005; 2: 8
- Manil L, Couvreur P, Mahieu P. Acute renal toxicity of doxorubicin (adriamycin)-loaded cyanoacrylate nanoparticles. Pharm Res. Jan, 1995; 12(1)85–87
- Antonovych TT. Gold nephropathy. Ann Clin Lab Sci. Sep–Oct, 1981; 11(5)386–391